Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer.
about
Weighted change-point method for detecting differential gene expression in breast cancer microarray dataBoth Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and functionAggressiveness Niche: Can It Be the Foster Ground for Cancer Metastasis Precursors?Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune DiseasesContribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinomaSpt2p defines a new transcription-dependent gross chromosomal rearrangement pathway.Relationship between Advanced Glycation End Products and Steroidogenesis in PCOSPurification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)Advanced glycation end products (AGE) induce the receptor for AGE in the colonic mucosa of azoxymethane-injected Fischer 344 rats fed with a high-linoleic acid and high-glucose dietTranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell ProliferationRadon-induced proteomic profile of lung tissue in rats.High-mobility group box 1 and cancer.Antitumor immunity induced after α irradiationConcurrent alterations of RAGE, RECK, and MMP9 protein expression are relevant to Epstein-Barr virus infection, metastasis, and survival in nasopharyngeal carcinoma.Co-expression of RAGE and HMGB1 is associated with cancer progression and poor patient outcome of prostate cancer.Alternatively spliced RAGEv1 inhibits tumorigenesis through suppression of JNK signalingPsoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation.Protumoral roles of melanoma inhibitory activity 2 in oral squamous cell carcinomaCell migration is regulated by AGE-RAGE interaction in human oral cancer cells in vitro.The association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review.RAGE genetic polymorphisms are associated with risk, chemotherapy response and prognosis in patients with advanced NSCLCHMGB1 in health and disease.RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma.Alternative splicing of the RAGE cytoplasmic domain regulates cell signaling and function.Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophagesThe association of HMGB1 gene with the prognosis of HCC.High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.Overexpression of the Receptor for Advanced Glycation Endproducts (RAGE) is associated with poor prognosis in gastric cancer.Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies.DAMPs, ageing, and cancer: The 'DAMP Hypothesis'.Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer.Amphoterin as an extracellular regulator of cell motility: from discovery to disease.Polyphenols and human health: prevention of disease and mechanisms of action.Expression of the receptor for advanced glycation end-products and frequency of polymorphism in lung cancer.Clinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosis.Prognostic Significance of Tag SNP rs1045411 in HMGB1 of the Aggressive Gastric Cancer in a Chinese Population.Impact of Oxidative Stress Biomarkers and Carboxymethyllysine (an Advanced Glycation End Product) on Prostate Cancer: A Prospective Study.The Role of receptor for Advanced Glycation End Products (RAGE) in the proliferation of hepatocellular carcinomaCancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesotheliomaExpression of MAS1 in breast cancer.
P2860
Q21134908-6DE141FD-144D-4F8F-8382-F80913407063Q24318378-8F4936F0-7220-49A4-848F-D8507C7379A1Q26738966-ABA6D72A-5DAF-459D-BC40-54FB8BE6FB81Q26768480-685F1633-941E-4EB5-A179-68F59C0015E2Q26781477-893F8107-2BC5-424E-A910-316D915A7C0CQ27938023-4B0AAC9A-8F5C-455B-984F-1B1D52F5BF21Q28077960-06769FA3-B8FB-4EAC-B13F-D7A1FED8DE17Q28508886-F051C0FD-E56F-476A-B7B2-9A62104AD4FAQ28568711-3F3A0DFF-D001-40A5-9030-23C5C4337A03Q31102154-60390C56-00A7-45BF-9611-05F7A4297921Q33317999-4BCFDF9F-23EC-44E1-94D2-81B5F4288298Q33638306-FFFB06D7-BE8A-4882-9C11-A355DCBA2AB1Q33891246-23589002-4F10-4B65-8F8B-9A739258D2E7Q33898573-B7BC75B2-EC49-42EA-8483-D6DDB7342258Q33932673-6D7913FE-F5AB-4E17-9716-A302027AA927Q34056610-A71C5906-E0C7-462B-A0E8-C0B6B7FEC712Q34242174-B256E171-A2E5-4A12-862F-28094D128F77Q34334079-7797B0A0-9B6B-4A4D-834B-96758DE0D71BQ34352301-29820A5C-956F-4FD0-84F2-03FB87C1D71AQ34428389-965A5491-F282-4D91-BC50-DA0E98673B69Q34446751-D77BB95C-1EF6-4DA3-AD81-931C6ABCF424Q34622835-DF67F855-E420-427D-86CD-2A3AC8BD707BQ34716082-F9D559A8-2BEC-4120-8C29-406BDF002675Q35048039-C035F507-413A-43B4-B39E-00AF7584628AQ35083684-1A9C07FB-D22C-45F4-A203-4B9D1ABC0BC5Q35106665-141EE941-F527-4DA6-ACC6-FE9DA9858474Q35188596-2D41DA15-C2A0-4F54-A81C-900B295D2AE2Q35364536-E6994C75-B6FB-4F72-8E1C-83CABA19AB9AQ35545467-5CE85417-33F5-4DB4-8D73-E2F08C29F079Q35558632-A66FDB8A-E967-4BA3-8FF0-FA78C4E8DE85Q35658529-F4B006AF-FA75-433B-B0BF-35D0711ED610Q35661145-5A3CE7B5-7320-496A-AD4D-C24C764B5E0CQ35670850-3E7D55E8-898C-4A1F-A2D2-AF1277F7071DQ35803624-561631E3-93A2-43C6-AA6B-3DBF18DA56D4Q35941788-47D69A50-76ED-42C2-B01D-73434A88B7F0Q35999764-D6320C59-DFE9-4BDB-B4B4-ED11CC59F284Q36042465-8B45D627-CB86-4563-9711-3CA2E5CC3B89Q36057340-CE0983F6-0CB8-42B7-AC7A-0F2BCD915336Q36074728-BE967AD9-53E9-4371-9C59-7ADC92C0F8A6Q36092905-E37196FA-419B-46E2-9335-B6DC205238D6
P2860
Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Expression of receptors for ad ...... ic activity of gastric cancer.
@en
type
label
Expression of receptors for ad ...... ic activity of gastric cancer.
@en
prefLabel
Expression of receptors for ad ...... ic activity of gastric cancer.
@en
P2093
P2860
P356
P1476
Expression of receptors for ad ...... ic activity of gastric cancer.
@en
P2093
Atsuko Wakikawa
Hideo Shigeishi
Hiroki Kuniyasu
Hiroshi Yokozaki
Kazuya Kuraoka
Naohide Oue
Norimasa Matsutani
Wataru Yasui
P2860
P304
P356
10.1002/PATH.1031
P577
2002-02-01T00:00:00Z